艾柯医疗IPO终止：3年收入不足百万元累亏2.28亿元

GPLP04-12

4月11日，上交所发布公告称，艾柯医疗器械 ( 北京 ) 股份有限公司（下称“艾柯医疗”）上市审核状态变更为“终止”，原因系该公司及保荐人中信证券主动撤回科创板上市申请。招股书显示，艾柯医疗成立于2017年，是一家已进入商业化阶段的专注于神经介入领域的创新医疗器械企业，注册资本为4308.4236万元，实控人为吕树铣、吕怡然，二人系父子关系，合计持有该公司44.40%的股份。此次IPO，艾柯...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2427760638?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-04-12 13:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2427760638","market":"us","top_or_hot":-1,"title":"艾柯医疗IPO终止：3年收入不足百万元 累亏2.28亿元","media":"GPLP","content":"<div>\n<p>4月11日，上交所发布公告称，艾柯医疗器械 ( 北京 ) 股份有限公司（下称“艾柯医疗”）上市审核状态变更为“终止”，原因系该公司及保荐人中信证券主动撤回科创板上市申请。\n招股书显示，艾柯医疗成立于2017年，是一家已进入商业化阶段的专注于神经介入领域的创新医疗器械企业，注册资本为4308.4236万元，实控人为吕树铣、吕怡然，二人系父子关系，合计持有该公司44.40%的股份。\n此次IPO，艾柯...</p>\n\n<a href=\"https://new.qq.com/rain/a/20240412A04LX900\">网页链接</a>\n\n</div>\n","source":"tencent_tech","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>艾柯医疗IPO终止：3年收入不足百万元 累亏2.28亿元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n艾柯医疗IPO终止：3年收入不足百万元 累亏2.28亿元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-12 13:10 北京时间&nbsp;&nbsp;&nbsp;<a href=https://new.qq.com/rain/a/20240412A04LX900><strong>GPLP</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>4月11日，上交所发布公告称，艾柯医疗器械 ( 北京 ) 股份有限公司（下称“艾柯医疗”）上市审核状态变更为“终止”，原因系该公司及保荐人中信证券主动撤回科创板上市申请。\n招股书显示，艾柯医疗成立于2017年，是一家已进入商业化阶段的专注于神经介入领域的创新医疗器械企业，注册资本为4308.4236万元，实控人为吕树铣、吕怡然，二人系父子关系，合计持有该公司44.40%的股份。\n此次IPO，艾柯...</p>\n\n<a href=\"https://new.qq.com/rain/a/20240412A04LX900\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1100","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://new.qq.com/rain/a/20240412A04LX900","article_id":"2427760638","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20240412A04LX900","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2427760638","pubTimestamp":1712898647,"sourceInfo":{"source_id":"tencent_tech","name":"腾讯科技"},"weMediaInfo":null,"summary":"4月11日，上交所发布公告称，艾柯医疗器械 ( 北京 ) 股份有限公司（下称“艾柯医疗”）上市审核状态变更为“终止”，原因系该公司及保荐人中信证券主动撤回科创板上市申请。      招股书显示，艾柯....","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1100":"医疗保健设备","BK1574":"生物医药B类股","09996":"沛嘉医疗-B","BK1222":"医疗保健用品","09997":"康基医疗","BK1583":"高瓴概念"},"translate_title":"Aike Medical's IPO terminated: 3 years of revenue less than one million yuan and a cumulative loss of 228 million yuan","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09996":0.71,"09997":0.71},"content_text":"4月11日，上交所发布公告称，艾柯医疗器械 ( 北京 ) 股份有限公司（下称“艾柯医疗”）上市审核状态变更为“终止”，原因系该公司及保荐人中信证券主动撤回科创板上市申请。\n招股书显示，艾柯医疗成立于2017年，是一家已进入商业化阶段的专注于神经介入领域的创新医疗器械企业，注册资本为4308.4236万元，实控人为吕树铣、吕怡然，二人系父子关系，合计持有该公司44.40%的股份。\n此次IPO，艾柯医疗拟公开发行股票数量不超过1436.1412万股，拟募资10.39亿元，计划用于神经介入医疗器械生产建设项目、神经介入医疗器械研发项目、营销网络建设项目、补充流动资金。\n业绩方面，2020年、2021年，艾柯医疗并无营收，2022年营收为90.09万元，2020-2022年扣非净亏损分别为3696.75万元、9593.3万元、1.06亿元，3年营收不足百万元，而亏损高达2.28亿元，累计未弥补亏损为8319.14万元。","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2427760638"}

艾柯医疗IPO终止：3年收入不足百万元 累亏2.28亿元

精彩评论

艾柯医疗IPO终止：3年收入不足百万元累亏2.28亿元